Â鶹ÊÓƵ

Paul, Weiss advised Amedisys, Inc., a leading provider of home health, hospice and high-acuity care, in its all-cash acquisition by UnitedHealth Group subsidiary Optum for $101 per share, valuing the company at $3.3 billion. The combination creates a scaled national platform for home and alternate site care.

The deal closed following a settlement with the U.S. Department of Justice, which had sued to block the merger in November 2024. The settlement includes an agreement from Amedisys and UnitedHealth to divest 164 home health and hospice locations in 19 states, and is subject to final approval by a Maryland federal judge.

The Paul, Weiss team was led by partners Krishna Veeraraghavan, Kyle Seifried, Benjamin Goodchild, Katherine Forrest, Robert Sperling and Geoffrey Chepiga, and included corporate partners Christopher Cummings and Matthew Leist and counsel Steve Centa; litigation partners Staci Yablon and Jacqueline Rubin; antitrust partner Marta Kelly; executive compensation partner Jean McLoughlin and counsel Cynthia Akard; tax partner Brian Krause; and intellectual property partner Jonathan Ashtor.